Techcyte
About Techcyte
Techcyte is a leading healthcare AI company transforming the practice of pathology through its unified, AI-powered digital platform. Founded in 2013, the company leverages deep machine learning to digitize lab workflows and enhance the efficiency and accuracy of diagnostic testing across human, animal, and environmental health. Their flagship “Fusion” platform integrates AI, digital workflows, and laboratory information systems (LIS) to streamline case review, standardize processes, and enable scalable diagnostic operations, directly addressing challenges faced by laboratories such as increasing test volumes, limited resources, and ongoing workforce shortages.
For physicians, Techcyte’s solutions offer significant advancements in both anatomic and clinical pathology. The platform provides AI-powered analysis of whole slide microscopy images, assisting lab professionals and pathologists in making quicker, more accurate diagnoses. This includes applications in parasitology, hematology, cervical cytology, bacteriology, and bladder cancer surveillance, with specific products like the Fusion AP, Fusion Parasitology Suite, and Techcyte SureView® Cervical Cytology System. The technology aims to reduce manual analysis time, improve consistency, and expand access to diagnostic expertise through digital and remote operations, with some solutions reducing analysis time to 15 to 30 seconds.
Techcyte’s commitment to innovation is further demonstrated through strategic collaborations, including a significant partnership with Mayo Clinic to develop new AI algorithms and workflows, and access to Mayo Clinic’s extensive de-identified pathology dataset of over 17 million slides. The company’s platform is CE-IVDD marked in Europe, and while some products are for Research Use Only (RUO) in the U.S., their continuous development aims to transform global pathology practices by delivering impactful AI solutions.
Focus Areas
Business Intelligence
| Key Investors | Van Tuyl Companies, Zoetis, Mayo Clinic, ARUP Laboratories, Atomic (Private Equity), University of Utah, Motic, BroadOak Capital Partners, Atua Ventures |
| Partnerships | Mayo Clinic, Zoetis, ARUP Laboratories, BD, CytoBay Labs, Aiforia, Voicebrook, Pramana, Aiosyn, Modella AI, Hamamatsu Corporation (U.S.), Mindpeak, Ketterthill, CorePlus, Apacor, Grundium, BIOBASE |
| Technology | Cloud-native, unified anatomic and clinical pathology AI platform (Techcyte Fusion®), deep machine learning for image analysis, integrates with EHR, LIS, grossing, and radiology systems, workflow automation, edge AI technology, HIPAA compliant, CE-IVDD marked |
| FDA Clearances | 0 (Products are Research Use Only in the US, with CE-IVDD and UKCA registrations for some solutions in Europe) cleared products (estimated) |
What Physicians Need to Know
For physicians, Techcyte's Fusion platform offers several key advantages. It significantly **improves diagnostic accuracy and consistency** by reducing technologist stress and fatigue and eliminating confirmation bias through AI-powered analysis. You can expect **faster turnaround times** for diagnoses, with some analyses reducing to 15-30 seconds per slide, allowing for quicker patient management. The platform provides **streamlined and unified workflows**, eliminating the need for multiple logins and fragmented systems, centralizing case management, AI analysis, collaboration, and reporting. This also fosters **enhanced collaboration** through built-in messaging, case sharing, and consultation features. Furthermore, its browser-based, multi-monitor support enables a **flexible work environment**, allowing pathologists to work from anywhere. The **open AI marketplace** allows integration of both Techcyte's proprietary and third-party AI algorithms, providing access to a broad suite of advanced diagnostic tools. Finally, the platform supports **comprehensive and structured reporting** with seamless LIS/EHR integration, reducing manual entry and errors.
Techcyte Fusion is built on an open, standards-based platform, ensuring seamless integration with existing laboratory infrastructure. It supports all major scanner vendors and is designed for interoperability with EHR, LIS, grossing, and radiology systems using industry standards like FHIR, HL7, and DICOM. The platform also features an 'AI marketplace' that allows for the integration of Techcyte's own AI algorithms, in-house developed algorithms, and third-party AI solutions from partners like Aiforia, Aiosyn, and Mindpeak, orchestrating them directly into clinical workflows.
What the Web Says
Techcyte is a company focused on developing AI-powered solutions for digital diagnostics in anatomic and clinical pathology. Their products aim to enhance the capabilities of laboratories and professionals by streamlining diagnostic processes and improving efficiency. However, employee reviews suggest significant issues with company culture, management, and work-life balance.
Overall: NegativeStrengths
- AI-assisted solutions for digital pathology enhance diagnostic accuracy and streamline workflows.
- Products like the Cervical Cytology System aim to minimize the number of cells needing assessment while highlighting critical ones.
- Offers a unified anatomic and clinical digital pathology platform (Techcyte Fusion).
- Collaborates with notable organizations like Mayo Clinic Platform and BD.
- Some employees found it a good place to start their careers.
- The company offers 100% remote work for some positions.
Limitations
- Extreme negativity and toxicity in company culture.
- Chaotic and clueless leadership.
- Insane pressure, unethical practices, and constant blame.
- Poor work-life balance.
- Low ratings for pay and benefits, job security, and advancement.
- Quality standards were extreme, but systems were broken.
Based on reviews from: Indeed.com, Slashdot, Techcyte.com, G2.com
Last updated: 2026-08-10
Videos
News, demos, and interviews about Techcyte.
Videos load interactively. If none appear, search YouTube for Techcyte →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]